Charming Medical

Charming Medical ROE

The Return on Equity (ROE) of Charming Medical (MCTA) as of Oct 17, 2026 is -0.44 %. In the previous year, Return on Equity (ROE) was 2,435.04 % — a change of -100.02% (lower).

ROE

-0.44 %

YoY

-100.02%

Last updated:

In 2026, Charming Medical's return on equity (ROE) was -0.44 %, a -100.02% increase from the 2,435.04 % ROE in the previous year.

The Charming Medical ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2023
26.33 USD
Jan 1, 2024
-72.06 USD
Jan 1, 2025
2,435.04 USD
Jan 1, 2026
-0.44 USD
The Charming Medical ROE history
YEARROEYoY
-0.44 %-100.02%
2,435.04 %-3,479.32%
-72.06 %-373.62%
26.33 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Charming Medical Stock analysis

What does Charming Medical do? Charming Medical Ltd, listed under the ticker MCTA with ISIN VGG205281089, is a Hong Kong-based company operating within the Consumer Discretionary sector, specifically in the Diversified Consumer Services industry. The company is structured as an investment holding entity focused on delivering beauty, wellness, and postpartum services through traditional Chinese medicine (TCM) methodologies. Its service portfolio includes womb-warming therapy, beauty treatments, tailor-made slimming programs, pelvic detox therapy, agarwood moxibustion treatments, and TCM-inspired prenatal massages. Additionally, Charming Medical Ltd offers TCM-inspired supplement products such as home herbal uterine care patches, probiotic intimate wash, and Yin nourishing pill sets. The company also provides technical training in TCM-inspired therapies, dietary therapy, and consultancy services to other businesses in the beauty and wellness sectors, including salons and massage centers. Charming Medical Ltd is scheduled to hold its initial public offering (IPO) on October 21, 2025. The company’s headquarters location within Hong Kong is not publicly specified. The firm’s business model integrates traditional Chinese medicine practices with modern consumer service offerings, targeting a niche market that emphasizes holistic health and wellness solutions. Its services and products are designed to cater to specific health and beauty needs, particularly for women, with a focus on postpartum care and TCM-based wellness approaches. The company’s operations reflect a blend of service delivery and product sales, with an emphasis on traditional practices adapted for contemporary consumer markets. No additional financial figures, historical data, or specific founding details are provided in the available information. Charming Medical is one of the most popular companies on Eulerpool.

ROE Details

Decoding Charming Medical's Return on Equity (ROE)

Charming Medical's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Charming Medical's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Charming Medical's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Charming Medical’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Charming Medical stock

Return on Equity (ROE) of Charming Medical is -0.44 % in 2026.

Return on Equity (ROE) of Charming Medical changed from 2,435.04 % to -0.44 %, representing a -100.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Charming Medical since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Charming Medical with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Charming Medical

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Charming Medical